A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease
Clinical trial NCT03976349 · COMPLETED
Trial details
- NCT number
- NCT03976349
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2024-08-12
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.